Multifaceted interactions of bacterial toxins with the gastrointestinal mucosa

Future Microbiology

Volumn 6, Issue 7, 2011, Pages 763-797

  Popoff, M R ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

diarrhea; enteritis; enterocyte; enterotoxin; fluid secretion; gastroenteritis; toxin

Indexed keywords

BACTERIAL TOXIN; BOTULINUM TOXIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CEREULIDE; CHOLERA TOXIN; CHOLESTEROL; CLAUDIN; CLOSTRIDIUM TOXIN; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; DEOXYRIBONUCLEASE; ELONGATION FACTOR 2; FODRIN; GANGLIOSIDE GM1; GUANOSINE TRIPHOSPHATASE; GUANYLATE CYCLASE; LAMININ; LISTERIOLYSIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3; MEMBRANE PROTEIN; PROTEINASE; RIBONUCLEASE; RIBOSOME RNA; SEROTONIN 3 RECEPTOR; SHIGA TOXIN; STAPHYLOCOCCUS ENTEROTOXIN; T LYMPHOCYTE RECEPTOR; UNINDEXED DRUG; UVOMORULIN;

ACUTE DIARRHEA; AEROMONAS HYDROPHILA; BACILLUS CEREUS; CELL DEATH; CELL INTERACTION; CELL SURFACE; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM SEPTICUM; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME ACTIVITY; GASTROINTESTINAL MUCOSA; HELICOBACTER PYLORI; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; INTESTINE CELL; LISTERIA MONOCYTOGENES; NONHUMAN; PRIORITY JOURNAL; REVIEW; SHIGELLA DYSENTERIAE; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; VIBRIO CHOLERAE; YERSINIA;

BACTERIA; BACTERIAL TOXINS; ENTEROTOXINS; EXOTOXINS; HUMANS; INTESTINAL MUCOSA; POISONING;

BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 79961081152     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.58     Document Type: Review

References (252)

1. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8(6), 411-420 (2008). (Pubitemid 351733416)
2. Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbi. PLoS Biol. 5(7), E177 (2007).
3. Stecher B, Hardt WD. The role of microbiota in infectious disease. Trends Microbiol. 16(3), 107-114 (2008).
4. Sansonetti PJ. War and peace at mucosal surfaces. Nat. Rev. Immunol. 4(12), 953-964 (2004). (Pubitemid 39620070)
5. Savarino SJ, Fasano A, Watson J et al. Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin. Proc. Natl Acad. Sci. USA 90, 3093-3097 (1993). (Pubitemid 23113564)
6. Menard LP, Dubreuil JD. Enteroaggregative Escherichia coli heat-stable enterotoxin 1 (EAST1): a new toxin with an old twist. Crit. Rev. Microbiol. 28(1), 43-60 (2002). (Pubitemid 34274339)
7. Dubreuil JD. Escherichia coli, Vibrio, and Yersinia species heat-stable enterotoxins. In: The Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands 798-817 (2006).
8. Giannella RA, Mann EA. E. coli heat-stable enterotoxin and guanylyl cyclase C: new functions and unsuspected actions. Trans. Am. Clin. Climatol. Assoc. 114, 67-85 (2003).
9. Vaandrager AB. Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C. Mol. Cell. Biochem. 230(1-2), 73-83 (2002). (Pubitemid 34257243)
10. Hasegawa M, Shimonishi Y. Recognition and signal transduction mechanism of Escherichia coli heat-stable enterotoxin and its receptor, guanylate cyclase C. J. Pept. Res. 65(2), 261-271 (2005). (Pubitemid 40327465)
11. Sellers ZM, Mann E, Smith A et al. Heat-stable enterotoxin of Escherichia coli (STa) can stimulate duodenal HCO3(-) secretion via a novel GC-C-and CFTR-independent pathway. FASEB J. 22(5), 1306-1316 (2008). (Pubitemid 351656772)
12. Sellers ZM, Childs D, Chow JY et al. Heat-stable enterotoxin of Escherichia coli stimulates a non-CFTR-mediated duodenal bicarbonate secretory pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 288(4), G654-G663 (2005). (Pubitemid 40388176)
13. Fasano A. Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin. Ann. NY Acad. Sci. 915, 214-222 (2000). (Pubitemid 32059382)
14. Gopalakrishnan S, Pandey N, Tamiz Ap et al. Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer. Int. J. Pharm. 365(1-2), 121-130 (2009).
15. Goldblum SE, Rai U, Tripathi A et al. The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation. FASEB J. 25, 144-158 (2010).
16. Trucksis M, Conn TL, Wasserman SS, Sears CL. Vibrio cholerae ACE stimulates Ca2+-dependent Cl-/HCO3-secretion in T84 cells in vitro. Am. J. Physiol. Cell Physiol. 279(3), C567-C577 (2000).
17. Chatterjee T, Mukherjee D, Dey S, Pal A, Hoque KM, Chakrbarti P. Accessory Cholera enterotoxin, ACE, from Vibrio cholerae: structure, unfolding, and virstatin binding. Biochemistry 50, 2962-2972 (2011).
18. Stenfors Arnesen LP, Fagerlund A, Granum PE. From soil to gut: Bacillus cereus and its food poisoning toxins. FEMS Microbiol. Rev. 32(4), 579-606 (2008). (Pubitemid 351799686)
19. Toh M, Moffitt MC, Henrichsen L et al. Cereulide, the emetic toxin of Bacillus cereus, is putatively a product of nonribosomal peptide synthesis. J. Appl. Microbiol. 97(5), 992-1000 (2004). (Pubitemid 39390226)
20. Agata N, Ohta M, Mori M, Isobe M. A novel dodecadepsipeptide, cereulide, is an emetic toxin of Bacillus cereus. FEMS Microbiol. Lett. 129(1), 17-20 (1995).
21. Horwood PF, Burgess GW, Oakey HJ. Evidence for non-ribosomal peptide synthetase production of cereulide (the emetic toxin) in Bacillus cereus. FEMS Microbiol. Lett. 236(2), 319-324 (2004). (Pubitemid 38900941)
22. Agata N, Ohta M, Mori M. Production of an emetic toxin, cereulide, is associated with a specific class of Bacillus cereus. Curr. Microbiol. 33(1), 67-69 (1996). (Pubitemid 26187161)
23. Andersson MA, Hakulinen P, Honkalampi-Hamalainen U et al. Toxicological profile of cereulide, the Bacillus cereus emetic toxin, in functional assays with human, animal and bacterial cells. Toxicon 49(3), 351-367 (2007). (Pubitemid 46201698)
24. Virtanen SM, Roivainen M, Andersson MA et al. In vitro toxicity of cereulide on porcine pancreatic Langerhans islets. Toxicon 51(6), 1029-1037 (2008).
25. Mikkola R, Saris NE, Grigoriev PA, Andersson MA, Salkinoja-Salonen MS. Ionophoretic properties and mitochondrial effects of cereulide: the emetic toxin of B. cereus. Eur. J. Biochem. 263(1), 112-117 (1999). (Pubitemid 29313845)
26. Saris NE, Andersson MA, Mikkola R et al. Microbial toxin's effect on mitochondrial survival by increasing K+ uptake. Toxicol. Ind. Health 25(7), 441-446 (2009).
27. Teplova VV, Mikkola R, Tonshin AA, Saris NE, Salkinoja-Salonen MS. The higher toxicity of cereulide relative to valinomycin is due to its higher affinity for potassium at physiological plasma concentration. Toxicol. Appl. Pharmacol. 210(1-2), 39-46 (2006). (Pubitemid 41790549)
28. Krakauer T, Stiles BG. Staphylococcal enterotoxins, toxic-shock syndrome toxin-1, and streptococcal pyrogenic exotoxins: some basic biology of bacterial superantigens. Rec. Res. Dev. Infect. Immun. 1, 1-27 (2003).
29. Jett M, Brinkley W, Neill R, Gemski P, Hunt R. Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness. Infect. Immun. 58(11), 3494-3499 (1990). (Pubitemid 20353343)
30. Alber G, Scheuber PH, Reck B, Sailer-Kramer B, Hartmann A, Hammer DK. Role of substance P in immediate-type skin reactions induced by staphylococcal enterotoxin B in unsensitized monkeys. J. Allergy Clin. Immunol. 84(6 Pt 1), 880-885 (1989). (Pubitemid 20022956)
31. Tiegs G, Bang R, Neuhuber WL. Requirement of peptidergic sensory innervation for disease activity in murine models of immune hepatitis and protection by b-adrenergic stimulation. J. Neuroimmunol. 96(2), 131-143 (1999). (Pubitemid 29234487)
32. Wang X, Wang BR, Zhang XJ, Duan XL, Guo X, Ju G. Fos expression in the rat brain after intraperitoneal injection of Staphylococcus enterotoxin B and the effect of vagotomy. Neurochem. Res. 29(9), 1667-1674 (2004). (Pubitemid 39070056)
33. Hu DL, Zhu G, Mori F et al. Staphylococcal enterotoxin induces emesis through increasing serotonin release in intestine and it is downregulated by cannabinoid receptor 1. Cell. Microbiol. 9(9), 2267-2277 (2007). (Pubitemid 47250297)
34. Beattie DT, Smith JA. Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch. Pharmacol. 377(3), 181-203 (2008).
35. Sears CL. The toxins of Bacteroides fragilis. Toxicon 39, 1737-1746 (2001). (Pubitemid 32787005)
36. Sanfilippo L, Li CK, Seth R, Balwin TJ, Menozzi MG, Mahida YR. Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-b (TGF-b) by human colonic epithelial cells. Clin. Exp. Immunol. 119, 456-463 (2000). (Pubitemid 30146341)
37. Mcclane BA. Clostridium perfringens enterotoxin. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands 763-778 (2006).
38. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S. Clostridium perfringens enterotoxin binds to the second extracellualr loop of claudin-3, a tight junction integral membrane protein. FEBS Lett. 476, 258-261 (2000). (Pubitemid 30410828)
39. Winkler L, Gehring C, Wenzel A et al. Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3. J. Biol. Chem. 284(28), 18863-18872 (2009).
40. Van Itallie CM, Betts L, Smedley JG 3rd, Mcclane BA, Anderson JM. Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. J. Biol. Chem. 283(1), 268-274 (2008).
41. Caserta JA, Hale ML, Popoff MR, Stiles BG, Mcclane BA. Evidence that membrane rafts are not required for the action of Clostridium perfringens enterotoxin. Infect. Immun. 76(12), 5677-5685 (2008).
42. Singh U, Van Itallie CM, Mitic LL, Anderson JM, Mcclane BA. CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple complex species, one of which contains the tight junction protein occludin. J. Biol. Chem. 275, 18407-18417 (2000). (Pubitemid 30414798)
43. Smedley JG 3rd, Uzal FA, Mcclane BA. Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. Infect. Immun. 75(5), 2381-2390 (2007). (Pubitemid 46744328)
44. Singh U, Mitic LL, Wieckowski EU, Anderson JM, Mcclane BA. Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized CaCo-2 cells versus Vero cells. J. Biol. Chem. 276, 33402-33412 (2001).
45. Chakrabarti G, Mcclane BA. The importance of calcium influx, calpain and calmodulin for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin. Cell. Microbiol. 7(1), 129-146 (2005).
46. Smedley JG 3rd, Saputo J, Parker JC et al. Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity. Infect. Immun. 76(8), 3793-3800 (2008).
47. Fernandez Miyakawa ME, Pistone Creydt V, Uzal FA, Mcclane BA, Ibarra C. Clostridium perfringens enterotoxin damages the human intestine in vitro. Infect. Immun. 73(12), 8407-8410 (2005). (Pubitemid 41740333)
48. Fivaz M, Abrami L, Tsitrin F, Van Der Goot FG. Aerolysin from Aeromonas hydrophila and related toxins. Curr. Top. Microbiol. Immunol. 257, 35-52 (2001).
49. Gurcel L, Iacovache I, Van Der Goot FG. Aerolysin and related Aeromonas toxins. In: The Comprehensive Source Book of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands 606-620 (2006).
50. Thayumanavan T, Vivekanandhan G, Savithamani K, Subashkumar R. Incidence of haemolysin-positive and drug-resistant Aeromonas hydrophila in freshly caught finfish and prawn collected from major commercial fishes of coastal South India. FEMS Immunol. Med. Microbiol. 36, 41-45 (2003). (Pubitemid 36515082)
51. Melton JA, Tweten RK. Clostridium septicum pore-forming a-toxin. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands 623-630 (2006).
52. Krause KH, Fivaz M, Monod A, Van Der Goot FG. Aerolysin induces G-protein activation and Ca2+ release from intracellular stores in human granulocytes. J. Biol. Chem. 273, 18122-18129 (1998). (Pubitemid 28334729)
53. Gurcel L, Abrami L, Girardin S, Tschopp J, Van Der Goot FG. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126(6), 1135-1145 (2006). (Pubitemid 44380297)
54. Dinarello CA. A signal for the caspase-1 inflammasome free of TLR, immunity. Immunity 26, 383-385 (2007). (Pubitemid 46603007)
55. Chopra AK, Xu X, Ribardo D et al. The cytotoxic enterotoxin of Aeromonas hydrophila induces proinflammatory cytokine production and activates arachidonic acid metabolism in macrophages. Infect. Immun. 68, 2808-2818 (2000). (Pubitemid 30253860)
56. Galindo CL, Fadl AA, Sha J et al. Aeromonas hydrophila cytotoxic enterotoxin activates mitogen-activated protein kinases and induces apoptosis in murine macrophages and human intestinal epithelial cells. J. Biol. Chem. 279, 37597-37612 (2004). (Pubitemid 39195473)
57. Galindo CL, Sha J, Ribardo DA, Fadl AA, Pillai L, Chopra AK. Identification of Aeromonas hydrophila cytotoxic enterotoxin-induced genes in macrophages using microarrays. J. Biol. Chem. 278, 40198-40212 (2003). (Pubitemid 37248588)
58. Geny B, Popoff MR. Bacterial protein toxins and lipids: pore formation or toxin entry into cells. Biol. Cell 98, 667-678 (2006). (Pubitemid 44697058)
59. Sayeed S, Uzal FA, Fisher DJ et al. b toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model. Mol. Microbiol. 67(1), 15-30 (2008). (Pubitemid 350231133)
60. Fernandez-Miyakawa ME, Fisher DJ, Poon R et al. Both e-toxin and b-toxin are important for the lethal properties of Clostridium perfringens type B isolates in the mouse intravenous injection model. Infect. Immun. 75(3), 1443-1452 (2007). (Pubitemid 46385838)
61. Fisher DJ, Fernandez-Miyakawa ME, Sayeed S et al. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Infect. Immun. 74(9), 5200-5210 (2006). (Pubitemid 44300439)
62. Poka H, Duke T. In search of pigbel: gone or just forgotten in the highlands of Papua New Guinea? PNG Med. J. 46(3-4), 135-142 (2003). (Pubitemid 43229391)
63. Gui L, Subramony C, Fratkin J, Hughson MD. Fatal enteritis necroticans (pigbel) in a diabetic adult. Mod. Pathol. 15(1), 66-70 (2002). (Pubitemid 34081461)
64. Matsuda T, Okada Y, Inagi E et al. Enteritis necroticans 'pigbel' in a Japanese diabetic adult. Pathol. Int. 57(9), 622-626 (2007). (Pubitemid 47222714)
65. Popoff MR, Bouvet P. Clostridial toxins. Future Microbiol. 4, 1021-1064 (2009).
66. Hunter SE, Brown E, Oyston Pcf, Sakurai J, Titball RW. Molecular genetic analysis of b-toxin of Clostridium perfringens reveals sequence homology with a-toxin, g-toxin, and leukocidin of Staphylococcus aureus. Infect. Immun. 61, 3958-3965 (1993). (Pubitemid 23260073)
67. Sakurai J. Toxins of Clostridium perfringens. Rev. Med. Microbiol. 6, 175-185 (1995).
68. Nagahama M, Morimitsu S, Kihara A, Akita M, Setsu K, Sakurai J. Involvement of tachykinin receptors in Clostridium perfringens b-toxin-induced plasma extravasation. Br. J. Pharmacol. 138(1), 23-30 (2003). (Pubitemid 36194199)
69. Nagahama M, Kihara A, Kintoh H, Oda M, Sakurai J. Involvement of tumour necrosis factor-a in Clostridium perfringens b-toxin-induced plasma extravasation in mice. Br. J. Pharmacol. 153(6), 1296-1302 (2008). (Pubitemid 351415517)
70. Steinthorsdottir V, Halldorson H, Andresson O. Clostridium perfringens b-toxin forms multimeric transmembrane pores in human endothelial cells. Microb. Pathog. 28, 45-50 (2000). (Pubitemid 30037815)
71. Shatursky O, Bayles R, Rogers M, Jost BH, Songer JG, Tweten RK. Clostridium perfringens b-toxin forms potential-dependent, cation-selective channels in lipid bilayers. Infect. Immun. 68, 5546-5551 (2000).
72. Nagahama M, Hayashi H, Morimitsu S, Sakurai J. Biological activities and pore formation of Clostridiium perfringens b toxin in HL60 cells. J. Biol. Chem. 278, 36934-36941 (2003). (Pubitemid 37140028)
73. Vidal JE, Mcclane BA, Saputo J, Parker J, Uzal FA. Effects of Clostridium perfringens b-toxin on the rabbit small intestine and colon. Infect. Immun. 76(10), 4396-4404 (2008).
74. Vidal JE, Ohtani K, Shimizu T, Mcclane BA. Contact with enterocyte-like CaCo-2 cells induces rapid upregulation of toxin production by Clostridium perfringens type C isolates. Cell. Microbiol. 11(9), 1306-1328 (2009).
75. Keyburn AL, Boyce JD, Vaz P et al. NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog. 4(2), E26 (2008).
76. Manich M, Knapp O, Gibert M et al. Clostridium perfringens d toxin is sequence related to b toxin, NetB, and Staphylococcus pore-forming toxins, but shows functional differences. PLoS ONE 3(11), E3764 (2008).
77. Chalmers G, Bruce HL, Hunter DB et al. Multilocus sequence typing analysis of Clostridium perfringens isolates from necrotic enteritis outbreaks in broiler chicken populations. J. Clin. Microbiol. 46(12), 3957-3964 (2008).
78. Truscott RB, Al-Sheikhly F. Reproduction and treatment of necrotic enteritis in broilers. Am. J. Vet. Res. 38(6), 857-861 (1977).
79. Keyburn AL, Sheedy SA, Ford ME et al. a-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens. Infect. Immun. 74(11), 6496-6500 (2006). (Pubitemid 44657433)
80. Mirza NN, Mccloud JM, Cheetham MJ. Clostridium septicum sepsis and colorectal cancer-a reminder. World J. Surg. Oncol. 7, 73 (2009).
81. El-Masry S. Spontaneous gas gangrene associated with occult carcinoma of the colon: a case report and review of literature. Int. Surg. 90(4), 245-247 (2005).
82. Pelletier JP, Plumbley JA, Rouse EA, Cina SJ. The role of Clostridium septicum in paraneoplastic sepsis. Arch. Pathol. Lab. Med. 124(3), 353-356 (2000). (Pubitemid 30152135)
83. Kennedy CL, Lyras D, Cordner LM et al. Pore-forming activity of a-toxin is essential for Clostridium septicum-mediated myonecrosis. Infect. Immun. 77(3), 943-951 (2009).
84. Knapp O, Stiles BG, Popoff MR. The aerolysin-like toxin family of cytolytic, pore-forming toxins. Open Toxinol. J. 3, 53-68 (2010).
85. Gordon VM, Nelson KL, Buckley JT et al. Clostridium septicum a-toxin uses glycosylphosphatidylinositol-anchored protein receptors. J. Biol. Chem. 274, 27274-27280 (1999).
86. Hong Y, Ohishi K, Inoue N et al. Requirement of N-glycan on GPI-anchored proteins for efficient binding of aerolysin but not Clostridium septicum a-toxin. EMBO J. 21(19), 5047-5056 (2002).
87. Kennedy CL, Smith DJ, Lyras D, Chakravorty A, Rood JI. Programmed cellular necrosis mediated by the pore-forming a-toxin from Clostridium septicum. PLoS Pathog. 5(7), E1000516 (2009).
88. Knapp O, Maier E, Mkaddem SB et al. Clostridium septicum a-toxin forms pores and induces rapid cell necrosis. Toxicon 55(1), 61-72 (2010).
89. Waldor MK, Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272, 1910-1914 (1996).
90. Hirst TR, D'souza JM. Vibrio cholerae and Escherichia coli thermolabile enterotoxin. In: The Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands 270-290 (2006).
91. Sanchez J, Holmgren J. Cholera toxin structure, gene regulation and pathophysiological and immunological aspects. Cell. Mol. Life Sci. 65(9), 1347-1360 (2008).
92. Vanden Broeck D, Horvath C, De Wolf MJ. Vibrio cholerae: cholera toxin. Int. J. Biochem. Cell. Biol. 39(10), 1771-1775 (2007). (Pubitemid 47321356)
93. De Haan L, Hirst TR. Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (review). Mol. Membr. Biol. 21(2), 77-92 (2004). (Pubitemid 38524366)
94. Sanchez J, Holmgren J. Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. Curr. Opin. Immunol. 17(4), 388-398 (2005). (Pubitemid 40848541)
95. Popoff MR, Poulain B. Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells. Toxins 2, 683-737 (2010).
96. Dubreuil JD. STb and AIDA-I: the missing link? Crit. Rev. Microbiol. 36(3), 212-220 (2010).
97. Albert MA, Kojic LD, Nabi IR, Dubreuil JD. Cell type-dependent internalization of Escherichia coli STb enterotoxin. FEMS Immunol. Med. Microbiol. 61(2), 205-217 (2011).
98. Dubreuil JD. Escherichia coli STb toxin and colibacillosis: knowing is half the battle. FEMS Microbiol. Lett. 278(2), 137-145 (2008). (Pubitemid 350264572)
99. Goncalves C, Vachon V, Schwartz JL, Dubreuil JD. The Escherichia coli enterotoxin STb permeabilizes piglet jejunal brush border membrane vesicles. Infect. Immun. 75(5), 2208-2213 (2007). (Pubitemid 46744307)
100. Kelly CP, Lamont JT. Clostridium difficile-more difficult than ever. N. Engl. J. Med. 359(18), 1932-1940 (2008).
101. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18(2), 247-263 (2005). (Pubitemid 40548293)
102. Genth H, Dreger SC, Huelsenbeck J, Just I. Clostridium difficile toxins: more than mere inhibitors of Rho proteins. Int. J. Biochem. Cell. Biol. 40(4), 592-597 (2008).
103. Lyras D, O'Connor JR, Howarth PM et al. Toxin B is essential for virulence of Clostridium difficile. Nature 458(7242), 1176-1179 (2009).
104. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467, 711-713 (2010).
105. Jank T, Aktories K. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 16(5), 222-229 (2008).
106. Barth H, Pfeifer G, Hofmann F, Maier E, Benz R, Aktories K. Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J. Biol. Chem. 276, 10670-10676 (2001). (Pubitemid 38089237)
107. Qa'dan M, Spyres LM, Ballard JD. pH-induced cytopathic effects of Clostridium sordellii lethal toxin. Infect. Immun. 69, 5487-5493 (2001). (Pubitemid 32786483)
108. Egerer M, Giesemann T, Herrmann C, Aktories K. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate. J. Biol. Chem. 284(6), 3389-3395 (2009).
109. Egerer M, Giesemann T, Jank T, Satchell KJ, Aktories K. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity. J. Biol. Chem. 282(35), 25314-25321 (2007). (Pubitemid 47372781)
110. Reineke J, Tenzer S, Rupnik M et al. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446(7134), 415-419 (2007). (Pubitemid 46474600)
111. Just I, Wilm M, Selzer J et al. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem. 270, 13932-13936 (1995).
112. Popoff MR, Chaves-Olarte E, Lemichez E et al. Ras, Rap, and rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. J. Biol. Chem. 271(17), 10217-10224 (1996). (Pubitemid 26131588)
113. Genth H, Aktories K, Just I. Monoglucosylation of RhoA at threonine 37 blocks cytosol membrane recycling. J. Biol. Chem. 274, 29050-29056 (1999).
114. Vetter IR, Hofmann F, Wohlgemuth S, Hermann C, Just I. Structural consequences of monoglucosylation of Ha-Ras by Clostridium sordellii lethal toxin. J. Mol. Biol. 301, 1091-1095 (2000).
115. Sehr P, Gili J, Genth H, Just I, Pick E, Aktories K. Glucosylation and ADP ribosylation of Rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling. Biochemistry 37, 5296-5304 (1998). (Pubitemid 28176531)
116. Hermann C, Ahmadian MR, Hofmann F, Just I. Functional consequences of monoglucosylation of Ha-Ras at effector domain amino acid threonine 35. J. Biol. Chem. 273, 16134-16139 (1998). (Pubitemid 28311384)
117. Chen ML, Pothoulakis C, Lamont JT. Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A. J. Biol. Chem. 277, 4247-4254 (2002). (Pubitemid 34968688)
118. Nusrat A, Von Eichel-Streiber C, Turner JR, Verkade P, Madara JL, Parkos CA. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect. Immun. 69, 1329-1336 (2001). (Pubitemid 32187577)
119. Boehm C, Gibert M, Geny B, Popoff MR, Rodriguez P. Modification of epithelial cell barrier permeability and intercellular junctions by Clostridium sordellii lethal toxin. Cell. Microbiol. 8, 1070-1085 (2006). (Pubitemid 43871643)
120. Geny B, Grassart A, Manich M et al. Rac1 inactivation by lethal toxin from Clostridium sordellii modifies focal adhesions upstream of actin depolymerization. Cell. Microbiol. 12, 217-232 (2010).
121. Kim H, Rhee SH, Pothoulakis C, Lamont JT. Clostridium difficile toxin A binds colonocyte Src causing dephosphorylation of focal adhesion kinase and paxillin. Exp. Cell. Res. 315(19), 3336-3344 (2009).
122. Nam HJ, Kang JK, Kim SK et al. Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation. J. Biol. Chem. 285(43), 32888-32896 (2010).
123. Just I, Hofmann F, Aktories K. Molecular mechanism of action of the large clostridial cytotoxins. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 307-331 (2000).
124. Bluetow L, Flatau G, Chiu K, Boquet P, Ghosh P. Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1. Nature Struct. Biol. 8, 584-588 (2001). (Pubitemid 32613004)
125. Lemonnier M, Landraud L, Lemichez E. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol. Rev. 31(5), 515-534 (2007). (Pubitemid 47246181)
126. Mcnichol BA, Rasmussen SB, Carvalho HM, Meysick KC, O'Brien AD. Two domains of cytotoxic necrotizing factor type 1 bind the cellular receptor, laminin receptor precursor protein. Infect. Immun. 75(11), 5095-5104 (2007). (Pubitemid 350033596)
127. Wilson BA, Ho M. Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins. Future Microbiol. 5(8), 1185-1201 (2010).
128. Contamin S, Galmiche A, Doye A, Flatau G, Benmerah A, Boquet P. The p21 Rho-activating toxin cytotoxic necrotizing factor 1 is endocytosed by a clathrin-independent mechanism and enters the cytosol by an acidic-dependent membrane translocation. Mol. Biol. Cell 11, 1775-1787 (2000). (Pubitemid 30307912)
129. Knust Z, Blumenthal B, Aktories K, Schmidt G. Cleavage of Escherichia coli cytotoxic necrotizing factor 1 is required for full biologic activity. Infect. Immun. 77(5), 1835-1841 (2009).
130. Hopkins AM, Walsh SV, Verkade P, Boquet P, Nusrat A. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J. Cell Sci. 116(Pt 4), 725-742 (2003). (Pubitemid 36231311)
131. Popoff MR, Geny B. Multifaceted role of Rho, Rac, Cdc42 and Ras in intercellular junctions, lessons from toxins. Biochim. Biophys. Acta 1788(4), 797-812 (2009).
132. Schlegel N, Meir M, Spindler V, Germer CT, Waschke J. Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro. J. Cell. Physiol. 226(5), 1196-1203 (2011).
133. Popoff MR. Molecular biology of actin-ADP-ribosylating toxins. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany 275-302 (2000).
134. Petosa C, Collier JR, Klimpel KR, Leppla SH, Liddington RC. Crystal structure of the anthrax toxin protective antigen. Nature (Lond.) 385, 833-838 (1997). (Pubitemid 27106075)
135. Stiles BG, Hale ML, Marvaud JC, Popoff MR. Clostridium perfringens i toxin: characterization of the cell-associated i b complex. Biochem. J. 367, 801-808 (2002). (Pubitemid 35305719)
136. Barth H, Aktories K, Popoff MR, Stiles BG. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol. Mol. Biol. Rev. 68(3), 373-402 (2004). (Pubitemid 39238275)
137. Kaiser E, Haug G, Hliscs M, Aktories K, Barth H. Formation of a biologically active toxin complex of the binary Clostridium botulinum C2 toxin without cell membrane interaction. Biochemistry 45(44), 13361-13368 (2006). (Pubitemid 44707696)
138. Gibert M, Monier MN, Ruez R et al. Endocytosis and toxicity of clostridial binary toxins depend on a clathrin-independent pathway regulated by Rho-GDI. Cell. Microbiol. 13(1), 154-170 (2011).
139. Pust S, Barth H, Sandvig K. Clostridium botulinum C2 toxin is internalized by clathrin-and Rho-dependent mechanisms. Cell. Microbiol. 12(12), 1809-1820 (2010).
140. Bachmeyer C, Benz R, Barth H, Aktories K, Gibert M, Popoff MR. Interaction of Clostridium botulinum C2 toxin with lipid bilayer membranes and Vero cells: inhibition of channel function in chloroquine and related compounds in vitro and toxin action in vivo. FASEB J. 15, 1658-1660 (2001).
141. Barth H, Blöcker D, Behlke J et al. Cellular uptake of Clostridium botulinum C2 toxin requires oligomerization and acidification. J. Biol. Chem. 275(25), 18704-18711 (2000). (Pubitemid 30422828)
142. Knapp O, Benz R, Gibert M, Marvaud JC, Popoff MR. Interaction of Clostridium perfringens i-toxin with lipid bilayer membranes. J. Biol. Chem. 277, 6143-6152 (2002).
143. Gibert M, Marvaud JC, Pereira Y et al. Differential requirement for the translocation of clostridial binary toxins: I toxin requires a membrane potential gradient. FEBS Lett. 581, 1287-1296 (2007). (Pubitemid 46452601)
144. Haug G, Leemhuis J, Tiemann D, Meyer DK, Aktories K, Barth H. The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol. J. Biol. Chem. 278(34), 32266-32274 (2003). (Pubitemid 37048420)
145. Kaiser E, Pust S, Kroll C, Barth H. Cyclophilin A facilitates translocation of the Clostridium botulinum C2 toxin across membranes of acidified endosomes into the cytosol of mammalian cells. Cell. Microbiol. 11(5), 790-795 (2009).
146. Haug G, Aktories K, Barth H. The host cell chaperone Hsp90 is necessary for cytotxic action of the binary i-like toxins. Infect. Immun. 72, 3066-3068 (2004). (Pubitemid 38542441)
147. Nagahama M, Hagiyama T, Kojima T et al. Binding and internalization of Clostridium botulinum C2 toxin. Infect. Immun. 77(11), 5139-5148 (2009).
148. Aktories K. Bacterial Toxins: Tools in Cell Biology and Pharmacology. Chapman and Hall, London, UK (1997).
149. Aktories K. Bacterial protein toxins as tools in cell biology and pharmacology. In: Cellular Microbiology. Cossart P, Boquet P, Normark S, Rappuoli R (Eds). ASM Press, Washington, DC, USA 221-237 (2000).
150. Schwan C, Stecher B, Tzivelekidis T et al. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog. 5(10), E1000626 (2009).
151. Ohishi I. Structure and function of actin-adenosine-diphosphate- ribosylating toxins. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany, 253-273 (2000).
152. Richard JF, Mainguy G, Gibert M, Marvaud JC, Stiles BG, Popoff MR. Transcytosis of i toxin across polarized Caco-2 cell monolayers. Mol. Microbiol. 43, 907-917 (2002). (Pubitemid 34415715)
153. Heine K, Pust S, Enzenmuller S, Barth H. ADP-ribosylation of actin by the Clostridium botulinum C2 toxin in mammalian cells results in delayed caspase-dependent apoptotic cell death. Infect. Immun. 76(10), 4600-4608 (2008).
154. Barbut F, Decre D, Lalande V et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J. Med. Microbiol. 54(Pt 2), 181-185 (2005). (Pubitemid 40868005)
155. Mcellistrem MC, Carman RJ, Gerding DN, Genheimer CW, Zheng L. A hospital
156. Geric B, Rupnik M, Gerding DN, Grabnar M, Johnson S. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J. Med. Microbiol. 53(Pt 9), 887-894 (2004). (Pubitemid 39238395)
157. Cartman ST, Heap JT, Kuehne SA, Cockayne A, Minton NP. The emergence of 'hypervirulence' in Clostridium difficile. Int. J. Med. Microbiol. 300(6), 387-395 (2010).
158. Martin H, Willey B, Low DE et al. Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006. J. Clin. Microbiol. 46(9), 2999-3004 (2008).
159. Elliott B, Reed R, Chang BJ, Riley TV. Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clostridium difficile. Anaerobe 15(6), 249-251 (2009).
160. Navarro-Garcia F. Enteroaggregative Escherichia coli plasmid-encoded toxin. Future Microbiol. 5(7), 1005-1013 (2010).
161. Strauman MC, Harper JM, Harrington SM, Boll EJ, Nataro JP. Enteroaggregative Escherichia coli disrupts epithelial cell tight junctions. Infect. Immun. 78(11), 4958-4964 (2010).
162. Johannes L, Romer W. Shiga toxins-from cell biology to biomedical applications. Nat. Rev. Microbiol. 8(2), 105-116 (2010).
163. Sandvig K, Spilsberg B, Lauvrak SU, Torgersen ML, Iversen TG, Van Deurs B. Pathways followed by protein toxins into cells. Int. J. Med. Microbiol. 293(7-8), 483-490 (2004). (Pubitemid 38667570)
164. Falguières T, Mallard F, Baron C et al. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell 12, 2453-2468 (2001). (Pubitemid 33051968)
165. Johannes L. The epithelial cell cytoseleton and intracellualr trafficking. I. Shiga toxin B-subunit system: retrograde transport, intracellular vectorization, and more. Am. J. Physiol. Gastrointest. Liver Physiol. 10, G1-G7 (2002). (Pubitemid 34666156)
166. Lamaze C, Johannes L. Intracellular trafficking of bacterial and plant protein toxins. In: The Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier Academic Press, Amsterdam, The Netherlands 135-153 (2006).
167. Romer W, Berland L, Chambon V et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 450(7170), 670-675 (2007). (Pubitemid 350207679)
168. Windschiegl B, Orth A, Romer W et al. Lipid reorganization induced by Shiga toxin clustering on planar membranes. PLoS ONE 4(7), E6238 (2009).
169. Tesh VL. Induction of apoptosis by Shiga toxins. Future Microbiol. 5(3), 431-453 (2010).
170. Jorgensen R, Purdy AE, Fieldhouse RJ, Kimber MS, Bartlett DH, Merrill AR. Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae. J. Biol. Chem. 283(16), 10671-10678 (2008).
171. Cortes-Bratti X, Chaves-Olarte E, Lagergard T, Thelestam M. Cellular internalization of cytolethal distending toxin from Hemophilus ducreyi. Infect. Immun. 68, 6903-6911 (2000). (Pubitemid 32463401)
172. Cortes-Bratti X, Frisan T, Thelestam M. The cytolethal distending toxins induce DNA damage and cell cycle arrest. Toxicon 39, 1729-1736 (2001). (Pubitemid 32787004)
173. Thelestam M, Frisan T. Cytolethal distending toxins. In: The Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands 448-467 (2006).
174. Nougayrede JP, Homburg S, Taieb F et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313(5788), 848-851 (2006). (Pubitemid 44223356)
175. Nougayrede JP, Taieb F, De Rycke J, Oswald E. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 13(3), 103-110 (2005). (Pubitemid 40311892)
176. Cover TL, Blanke SR. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 3(4), 320-332 (2005). (Pubitemid 40443725)
177. Costa AC, Figueiredo C, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter 14(Suppl. 1), 15-20 (2009).
178. Isomoto H, Moss J, Hirayama T. Pleiotropic actions of Helicobacter pylori vacuolating cytotoxin, VacA. Tohoku J. Exp. Med. 220(1), 3-14 (2010).
179. Ricci V, Galmiche A, Doye A, Necchi V, Solcia E, Boquet P. High cell sensitivity to Helicobacter pylori VacA toxin depends on a GPI-anchored protein and is not blocked by inhibition of the clathrin-mediated pathway of endocytosis. Mol. Biol. Cell 11, 3897-3909 (2000).
180. Wang F, Xia P, Wu F et al. Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells. J. Biol. Chem. 283(39), 26714-26725 (2008).
181. Gauthier NC, Monzo P, Kaddai V, Doye A, Ricci V, Boquet P. Helicobacter pylro VacA cytotoxin: a probe for a clathrin-independent and Cdc42-dependent pinocytic pathway routed to late endosomes. Mol. Biol. Cell. 16, 4852-4866 (2005). (Pubitemid 41416465)
182. Galmiche A, Rassow J. Targeting of Helicobacter pylori VacA to mitochondria. Gut Microbes 1(6), 392-395 (2011).
183. Radin JN, Gonzalez-Rivera C, Ivie SE, Mcclain MS, Cover TL. Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells. Infect. Immun. 79(7), 2535-2543 (2011).
184. Sayeed S, Fernandez-Miyakawa ME, Fisher DJ et al. E-toxin is required for most Clostridium perfringens type D vegetative culture supernatants to cause lethality in the mouse intravenous injection model. Infect. Immun. 73(11), 7413-7421 (2005). (Pubitemid 41587644)
185. Goldstein J, Morris WE, Loidl CF et al. Clostridium perfringens e toxin increases the small intestinal permeability in mice and rats. PLoS ONE 4(9), E7065 (2009).
186. Tamai E, Ishida T, Miyata S et al. Accumulation of Clostridium perfringens e-toxin in the mouse kidney and its possible biological significance. Infect. Immun. 71(9), 5371-5375 (2003). (Pubitemid 37070786)
187. Uzal FA, Songer JG. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J. Vet. Diagn. Invest. 20(3), 253-265 (2008). (Pubitemid 352844373)
188. Minami J, Katayama S, Matsushita O, Matsushita C, Okabe A. l-toxin of Clostridium perfringens activates the precursor of e-toxin by releasing its N-and C-terminal peptides. Microbiol. Immunol. 41, 527-535 (1997). (Pubitemid 27318089)
189. Cole AR, Gibert M, Popoff MR, Moss DS, Titball RW, Basak A. Clostridium perfringens e-toxin shows structural similarity to the pore-forming toxin aerolysin. Nat. Struct. Mol. Biol. 11, 797-798 (2004). (Pubitemid 39014507)
190. Finnie JW. Neurological disorders produced by Clostridium perfringens type D e toxin. Anaerobe 10(2), 145-150 (2004). (Pubitemid 38519815)
191. Soler-Jover A, Dorca J, Popoff MR et al. Distribution of Clostridium perfringens e toxin in the brains of acutely intoxicated mice and its effect upon glial cells. Toxicon 50(4), 530-540 (2007). (Pubitemid 47368587)
192. Dorca-Arevalo J, Soler-Jover A, Gibert M, Popoff MR, Martin-Satue M, Blasi J. Binding of e-toxin from Clostridium perfringens in the nervous system. Vet. Microbiol. 131(1-2), 14-25 (2008).
193. Miyamoto O, Minami J, Toyoshima T et al. Neurotoxicity of Clostridium perfringens e-toxin for the rat hipocampus via glutamanergic system. Infect. Immun. 66, 2501-2508 (1998). (Pubitemid 28261744)
194. Petit L, Gibert M, Gillet D, Laurent-Winter C, Boquet P, Popoff MR. Clostridium perfringens e-toxin acts on MDCK cells by forming a large membrane complex. J. Bacteriol. 179, 6480-6487 (1997). (Pubitemid 27443933)
195. Shortt SJ, Titball RW, Lindsay CD. An assessment of the in vitro toxicology of Clostridium perfringens type D e-toxin in human and animal cells. Hum. Experim. Toxicol. 19, 108-116 (2000). (Pubitemid 30189872)
196. Miyata S, Minami J, Tamai E, Matsushita O, Shimamoto S, Okabe A. Clostridium perfringens e-toxin forms a heptameric pore within the detergent-insoluble microdomains of Madin-Darby canine kidney cells and rat synaptosomes. J. Biol. Chem. 277, 39463-39468 (2002). (Pubitemid 35190922)
197. Petit L, Maier E, Gibert M, Popoff MR, Benz R. Clostridium perfringens e-toxin induces a rapid change in cell membrane permeability to ions and forms channels in artificial lipid bilayers. J. Biol. Chem. 276, 15736-15740 (2001).
198. Petit L, Gibert M, Gourch A, Bens M, Vandewalle A, Popoff MR. Clostridium perfringens e toxin rapidly decreases membrane barrier permeability of polarized MDCK cells. Cell. Microbiol. 5, 155-164 (2003). (Pubitemid 36348032)
199. Chassin C, Bens M, De Barry J et al. Pore-forming e toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am. J. Physiol. Renal Physiol. 293(3), F927-F937 (2007). (Pubitemid 47403365)
200. Finnie JW. Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D e toxin: a review. Aust. Vet. J. 81(4), 219-221 (2003). (Pubitemid 43934479)
201. Zhu C, Ghabriel MN, Blumbergs PC et al. Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood brain barrier (BBB). Exp. Neurol. 169, 72-82 (2001). (Pubitemid 32424324)
202. Lonchamp E, Dupont JL, Wioland L et al. Clostridium perfringens e toxin targets granule cells in the mouse cerebellum and stimulates glutamate release. PLoS ONE 5(9), E13046 (2011).
203. Miyamoto O, Sumitami K, Nakamura T et al. Clostridium perfringens e toxin causes excessive release of glutamate in the mouse hippocampus. FEMS Microbiol. Lett. 189, 109-113 (2000). (Pubitemid 30456256)
204. Poulain B, Popoff MR, Molgo J. How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action. Botulinum J. 1, 14-87 (2008).
205. Ahsan CR, Hajnoczky G, Maksymowych AB, Simpson LL. Visualization of binding and transcytosis of botulinum toxin by human intestinal epithelial cells. J. Pharmacol. Exp. Ther. 315, 1028-1035 (2005). (Pubitemid 41635388)
206. Couesnon A, Pereira Y, Popoff MR. Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers. Cell. Microbiol. 10, 375-387 (2008).
207. Jin Y, Takegahara Y, Sugawara Y, Matsumura T, Fujinaga Y. Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins-differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. Microbiology 155(Pt 1), 35-45 (2009).
208. Maksymowych AB, Simpson LI. Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells. J. Pharmacol. Exp. Ther. 210, 633-641 (2004). (Pubitemid 38988908)
209. Maksymowych AB, Simpson LL. Binding and transcytosis of botulinum neurotoxin by polarized human carcinoma cells. J. Biol. Chem. 273, 21950-21957 (1998). (Pubitemid 28405374)
210. Matsumura T, Jin Y, Kabumoto Y et al. The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell. Microbiol. 10, 355-364 (2008).
211. Fujinaga Y, Matsumura T, Jin Y, Takegahara Y, Sugawara Y. A novel function of botulinum toxin-associated proteins: HA proteins disrupt intestinal epithelial barrier to increase toxin absorption. Toxicon 54(5), 583-586 (2009).
212. Sugawara Y, Matsumura T, Takegahara Y et al. Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin. J. Cell. Biol. 189(4), 691-700 (2010).
213. Nishiki T, Kamata Y, Nemoto Y et al. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J. Biol. Chem. 269(14), 10498-10503 (1994). (Pubitemid 24198248)
214. Jin R, Rummel A, Binz T, Brunger AT. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 444(7122), 1092-1095 (2006). (Pubitemid 46018531)
215. Rummel A, Karnath T, Henke T, Bigalke H, Binz T. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem. 279, 30865-30870 (2004). (Pubitemid 38938022)
216. Dong M, Richards DA, Goodnough MC, Tepp WH, Johnson EA, Chapman ER. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 162, 1293-1303 (2003). (Pubitemid 37210885)
217. Dong M, Yeh F, Tepp WH et al. SV2 is the protein receptor for botulinum neurotoxin A. Science 312, 592-596 (2006).
218. Mahrhold S, Rummel A, Bigalke H, Davletov B, Binz T. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett. 580, 2011-2014 (2006).
219. Dong M, Liu H, Tepp WH, Johnson EA, Janz R, Chapman ER. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol. Biol. Cell. 19(12), 5226-5237 (2008).
220. Vazquez-Boland JA, Stachowiak R, Lacharme L, Scortti M. Listeriolysin. In: The Source Book of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier Academic Press, Amsterdam, The Netherlands, 700-716 (2006).
221. Pizarro-Cerda J, Cossart P. Listeria monocytogenes membrane trafficking and lifestyle: the exception or the rule? Annu. Rev. Cell. Dev. Biol. 25, 649-670 (2009).
222. Glenn GM, Francis DH, Danielsen EM. Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines. Infect. Immun. 77(12), 5206-5215 (2009).
223. Titball RW. Clostridium perfringens vaccines. Vaccine 27(Suppl. 4), D44-D47 (2009).
224. Smith LA. Botulism and vaccines for its prevention. Vaccine 27(Suppl. 4), D33-D39 (2009).
225. Springer S, Selbitz HJ. The control of necrotic enteritis in sucking piglets by means of a Clostridium perfringens toxoid vaccine. FEMS Immunol. Med. Microbiol. 24(3), 333-336 (1999). (Pubitemid 29332611)
226. Boedeker EC. Vaccines for enterotoxigenic Escherichia coli: current status. Curr. Opin. Gastroenterol. 21(1), 15-19 (2005). (Pubitemid 40189218)
227. Sizemore DR, Roland KL, Ryan US. Enterotoxigenic Escherichia coli virulence factors and vaccine approaches. Expert Rev. Vaccines 3(5), 585-595 (2004). (Pubitemid 39440833)
228. Holmgren J, Czerkinsky C, Eriksson K, Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 21(Suppl. 2), S89-S95 (2003). (Pubitemid 36588654)
229. Holmgren J, Harandi AM, Czerkinsky C. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Expert Rev. Vaccines 2(2), 205-217 (2003). (Pubitemid 36559926)
230. Peppoloni S, Ruggiero P, Contorni M et al. Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. Expert Rev. Vaccines 2(2), 285-293 (2003). (Pubitemid 36564799)
231. Pizza M, Giuliani MM, Fontana MR et al. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19(17-19), 2534-2541 (2001). (Pubitemid 32234269)
232. Plant A, Williams NA. Modulation of the immune response by the cholera-like enterotoxins. Curr. Top. Med. Chem. 4(5), 509-519 (2004). (Pubitemid 38832734)
233. Salmond RJ, Luross JA, Williams NA. Immune modulation by the cholera-like enterotoxins. Expert Rev. Mol. Med. 4(21), 1-16 (2002).
234. Simmons CP, Ghaem-Magami M, Petrovska L et al. Immunomodulation using bacterial enterotoxins. Scand. J. Immunol. 53(3), 218-226 (2001). (Pubitemid 32193686)
235. Taxt A, Aasland R, Sommerfelt H, Nataro J, Puntervoll P. Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target. Infect. Immun. 78(5), 1824-1831 (2011).
236. Salama NN, Fasano A, Thakar M, Eddington ND. The impact of dG on the oral bioavailability of low bioavailable therapeutic agents. J. Pharmacol. Exp. Ther. 312(1), 199-205 (2005). (Pubitemid 40096469)
237. Hirschberg H, Zhang MJ, Gach HM et al. Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens e prototoxin. J. Neurooncol. 95(3), 317-329 (2009).
238. Fahrer J, Plunien R, Binder U, Langer T, Seliger H, Barth H. Genetically engineered clostridial C2 toxin as a novel delivery system for living mammalian cells. Bioconjug. Chem. 21(1), 130-139 (2011).
239. Barth H, Stiles BG. Binary actin-ADP-ribosylating toxins and their use as molecular Trojan horses for drug delivery into eukaryotic cells. Curr. Med. Chem. 15(5), 459-469 (2008). (Pubitemid 351472412)
240. Fahrer J, Rieger J, Van Zandbergen G, Barth H. The C2-streptavidin delivery system promotes the uptake of biotinylated molecules in macrophages and T-leukemia cells. Biol. Chem. 391(11), 1315-1325 (2011).
241. Marvaud JC, Stiles BG, Chenal A et al. Clostridium perfringens i toxin: mapping of the Ia domain involved in docking with Ib and cellular internalization. J. Biol. Chem. 277, 43659-43666 (2002). (Pubitemid 36157781)
242. Hirayama T, Wada A. Heat-stable enterotoxin of Escherichia coli. In: Bacterial Protein Toxins. Aktories K, Just I (Eds). Springer, Berlin, Germany 577-593 (2000).
243. Salama NN, Fasano A, Lu R, Eddington ND. Effect of the biologically active fragment of zonula occludens toxin, dG, on the intestinal paracellular transport and oral absorption of mannitol. Int. J. Pharm. 251(1-2), 113-121 (2003). (Pubitemid 36071466)
244. Alouf JE, Müller-Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects. Int. J. Med. Microbiol. 292, 429-440 (2003). (Pubitemid 36258454)
245. Prevost G, Mourey L, Colin DA, Menestrina G. Staphylococcal pore-forming toxins. Curr. Top. Microbiol. Immunol. 257, 53-83 (2001). (Pubitemid 32230025)
246. Basak A, Popoff MR, Titball RW, Cole AR. Clostridium perfringens ε-toxin. In: The Comprehensive Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands 631-642 (2006).
247. Sandvig K. The Shiga toxins: properties and action on cells. In: The Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Academic Press Elsevier, Amsterdam, The Netherlands 310-322 (2006).
248. Lara-Tajero M, Galan JE. Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions. Trends Microbiol. 10, 147-152 (2002). (Pubitemid 34178328)
249. Boquet P. The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli. Toxicon 39, 1673-1680 (2001). (Pubitemid 32786999)
250. Horiguchi Y. Escherichia coli cytotoxic necrotizing factors and Bordetella dermonecrotic toxin: the dermonecrosis-inducing toxins activating Rho small GTPases. Toxicon 39, 1619-1627 (2001). (Pubitemid 32786995)
251. Just I, Gerhard R. Large clostridial cytotoxins. Rev. Physiol. Biochem. Pharmacol. 152, 23-47 (2004). (Pubitemid 44404356)
252. Poulain B, Stiles BG, Popoff MR, Molgo J. Attack of the nervous system by clostridial toxins: physical findings, cellular and molecular actions. In: The Sourcebook of Bacterial Protein Toxins. Alouf JE, Popoff MR (Eds). Elsevier, Academic Press, Amsterdam, The Netherlands 348-389 (2006).